Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival (Q43837244)

27 November 2017

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival (English)

1 reference

27 November 2017

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Simone Ferrero

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Marco Ladetto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Daniela Drandi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Federica Cavallo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Elisa Genuardi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Roberto Passera

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

M Urbano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

S Caltagirone

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

M Grasso

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

F Rossini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

T Guglielmelli

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

C Cangialosi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

A M Liberati

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

V Callea

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

T Carovita

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

C Crippa

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

L De Rosa

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

F Pisani

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

A P Falcone

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

P Pregno

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

S Oliva

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

C Terragna

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

M Boccadoro

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

A Palumbo

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

16 July 2014

1 reference

27 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

689-695

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25027515%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2014.219

12 June 2020

exact match

0 references

cites work

Improved survival in multiple myeloma and the impact of novel therapies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

Importance of achieving a complete response in multiple myeloma, and the impact of novel agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

Molecular monitoring of minimal residual disease in the peripheral blood of patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

Approach to the treatment of multiple myeloma: a clash of philosophies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

Minimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

Deep sequencing reveals myeloma cells in peripheral blood in majority of multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.219

Real-Time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma

21 January 2018

1 reference

12 December 2020

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

1 reference

12 December 2020

High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma

1 reference

12 December 2020

The level of minimal residual disease in the bone marrow of patients with multiple myeloma before high-dose therapy and autologous blood stem cell transplantation is an independent predictive parameter

1 reference

12 December 2020

A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors

1 reference

12 December 2020